Annual EBITDA
-$133.82M$148.55M+52.61%
Summary
- Current Value
- As of today, ASND annual EBITDA is -$133.82M, up +52.61% on
- Historical Performance
- ASND annual EBITDA is up +76.59% over the past 3 years, up +63.45% over the past 5 years
- All-Time High Comparison
- ASND annual EBITDA is currently -1873.36% below its historical high of $7.55M set on
- 3-Year Low Comparison
- ASND annual EBITDA is +76.59% above its 3-year low of -$571.58M reached on an earlier date
- Sector Comparison
- ASND annual EBITDA is higher than 11.89% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$133.82M | +52.6% | +76.6% | +63.5% | – | |
| Quarterly EBITDA | $17.13M | +230.6% | +111.8% | +115.5% | – | |
| TTM EBITDA | -$125.35M | +55.8% | +78.1% | +65.9% | – | |
| Price | $240.65 | +58.8% | +111.9% | +63.8% | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $812.73M | +106.6% | +1411.1% | +10000.0% | – | |
| Annual EPS | -$4.25 | +39.9% | +61.1% | +55.0% | – | |
| -$153.79M | +49.0% | +74.0% | +59.2% | – | ||
| Annual Net Income | -$257.35M | +37.1% | +58.0% | +46.1% | – |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$133.82M | at high | |
| 5Y | -$133.82M | at high | |
| All | $7.55M | -1873.4% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$571.58M | N/A | +76.6% |
| 5Y | -$571.58M | +76.6% | |
| All | -$571.58M | +76.6% |
EBITDA History
FAQ
What is the current annual EBITDA of ASND?
As of today, ASND annual EBITDA is -$133.82M
What is 1-year change in ASND annual EBITDA?
ASND annual EBITDA is up +52.61% year-over-year
What is 3-year change in ASND annual EBITDA?
ASND annual EBITDA is up +76.59% over the past 3 years
How far is ASND annual EBITDA from its all-time high?
ASND annual EBITDA is currently -1873.36% below its historical high of $7.55M set on December 31, 2013
How does ASND annual EBITDA rank versus sector peers?
ASND annual EBITDA is higher than 11.89% of companies in Healthcare sector
When is ASND next annual earnings release?
As of today, the next annual earnings release for ASND has not been scheduled
Quarterly EBITDA
$17.13M$415.00K-2.36%
Summary
- Current Value
- As of today, ASND quarterly EBITDA is $17.13M, down -2.36% on
- Historical Performance
- ASND quarterly EBITDA is up +230.63% year-over-year, up +111.77% over the past 3 years
- All-Time High Comparison
- ASND quarterly EBITDA is currently -2.36% below its historical high of $17.55M set on
- 3-Year Low Comparison
- ASND quarterly EBITDA is +111.48% above its 3-year low of -$149.29M reached on
- Sector Comparison
- ASND quarterly EBITDA is higher than 80.99% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $17.13M | -2.4% | +230.6% | +111.8% | +115.5% | |
| Annual EBITDA | -$133.82M | – | +52.6% | +76.6% | +63.5% | |
| TTM EBITDA | -$125.35M | +8.7% | +55.8% | +78.1% | +65.9% | |
| Price | $240.65 | +17.1% | +58.8% | +111.9% | +63.8% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $288.07M | +15.4% | +55.3% | +1133.5% | +10000.0% | |
| Quarterly EPS | -$0.64 | +45.8% | +7.2% | +83.2% | +79.3% | |
| $11.52M | -10.4% | +2719.7% | +107.7% | +110.1% | ||
| Quarterly Net Income | -$39.06M | +45.2% | +4.8% | +81.5% | +76.4% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $17.55M | -2.4% | |
| 3Y | $17.55M | -2.4% | |
| 5Y | $17.55M | -2.4% | |
| All | $17.55M | -2.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$104.90M | +116.3% | |
| 3Y | -$149.29M | +111.5% | |
| 5Y | -$149.29M | +111.5% | |
| All | -$149.29M | +111.5% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ASND?
As of today, ASND quarterly EBITDA is $17.13M
What is ASND quarterly EBITDA most recent change?
ASND quarterly EBITDA was down -2.36% on December 31, 2025
What is 1-year change in ASND quarterly EBITDA?
ASND quarterly EBITDA is up +230.63% year-over-year
How far is ASND quarterly EBITDA from its all-time high?
ASND quarterly EBITDA is currently -2.36% below its historical high of $17.55M set on September 30, 2025
How does ASND quarterly EBITDA rank versus sector peers?
ASND quarterly EBITDA is higher than 80.99% of companies in Healthcare sector
When is ASND next earnings release?
The next earnings release for ASND is on
TTM EBITDA
-$125.35M$11.95M+8.70%
Summary
- Current Value
- As of today, ASND TTM EBITDA is -$125.35M, up +8.70% on
- Historical Performance
- ASND TTM EBITDA is up +55.79% year-over-year, up +78.07% over the past 3 years
- All-Time High Comparison
- ASND TTM EBITDA is currently -2281.47% below its historical high of $5.75M set on
- 3-Year Low Comparison
- ASND TTM EBITDA is +78.54% above its 3-year low of -$584.18M reached on
- Sector Comparison
- ASND TTM EBITDA is higher than 13.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$125.35M | +8.7% | +55.8% | +78.1% | +65.9% | |
| Annual EBITDA | -$133.82M | – | +52.6% | +76.6% | +63.5% | |
| Quarterly EBITDA | $17.13M | -2.4% | +230.6% | +111.8% | +115.5% | |
| Price | $240.65 | +17.1% | +58.8% | +111.9% | +63.8% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $823.12M | +14.2% | +110.0% | +1454.1% | +10000.0% | |
| TTM EPS | -$4.20 | +1.2% | +41.2% | +61.3% | +55.4% | |
| -$145.33M | +7.1% | +52.0% | +75.4% | +61.6% | ||
| TTM Net Income | -$253.97M | +0.8% | +38.0% | +58.3% | +47.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$125.35M | at high | |
| 3Y | -$125.35M | at high | |
| 5Y | -$125.35M | at high | |
| All | $5.75M | -2281.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$339.92M | +63.1% | |
| 3Y | -$584.18M | +78.5% | |
| 5Y | -$584.18M | +78.5% | |
| All | -$584.18M | +78.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ASND?
As of today, ASND TTM EBITDA is -$125.35M
What is ASND TTM EBITDA most recent change?
ASND TTM EBITDA was up +8.70% on December 31, 2025
What is 1-year change in ASND TTM EBITDA?
ASND TTM EBITDA is up +55.79% year-over-year
How far is ASND TTM EBITDA from its all-time high?
ASND TTM EBITDA is currently -2281.47% below its historical high of $5.75M set on December 31, 2013
How does ASND TTM EBITDA rank versus sector peers?
ASND TTM EBITDA is higher than 13.44% of companies in Healthcare sector
When is ASND next earnings release?
The next earnings release for ASND is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- ASND Official Website ascendispharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1612042/000119312526046590/0001193125-26-046590-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1612042/000119312526046590/0001193125-26-046590-index.htm
- ASND Profile on Yahoo Finance finance.yahoo.com/quote/ASND
- ASND Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/asnd